Selected Publications. Full Bibliography here
Fox AD, Navos Behrends C, Perez-Correa A, Riback L, Ohlendorf E, Ghiroli M, López-Castro T. High interest in injectable opioid agonist treatment with hydromorphone among NYC syringe service program participants. Subst Use Addctn. 2024 Jan;45(1):44-53.
Jakubowski A, Fox AD. Defining low-threshold buprenorphine treatment. J Addict Med. 2020 Mar/Apr;14(2):95-98.
Joudrey PJ, Khan MR, Wang EA, Scheidell JD, Edelman EJ, McInnes DK, Fox AD. A conceptual model for understanding post-release opioid-related overdose risk. Addict Sci Clin Pract. 2019 Apr 15;14(1):17.
Howell BA, Earnshaw VA, Garcia M, Taylor A, Martin K, Fox A. The stigma of criminal justice involvement and health: a conceptual framework. J Urban Health. 2022 Feb;99(1):92-101.
Hayes BT, Favaro J, Davis CS, Gonsalves GS, Beletsky L, Vlahov D, Heimer R, Fox AD. Harm Reduction, By Mail: the Next Step in Promoting the Health of People Who Use Drugs. J Urban Health. 2021; 98(4):532-537.
Hagan B, Wang EA, Aminawung JA, Albizu-Garcia C, Zaller N, Nyamu S, Shavit S, Deluca J, Fox AD. History of solitary confinement is associated with Post-Traumatic Stress Disorder symptoms among individuals recently released from prison. J Urban Health. 2018 Apr; 95(2): 141-8.
Maradiaga JA, Nahvi S, Cunningham CO, Sanchez J, Fox AD. “I kicked the hard way. I got incarcerated.” Withdrawal from methadone during incarceration and subsequent aversion to medication assisted treatments. J Subst Abuse Treat. 2016 Mar; 62: 49-54.
Gonzalez CM, Fox AD, Marantz PR. The evolution of an elective in health disparities and advocacy: description of instructional strategies and program evaluation. Acad Med. 2015 Dec; 90(12): 1636-40.